ENG/中
老虎證券
市场
行情
24/7新闻
产品
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
麥科醫藥-B
18.810
+2.480
15.19%
手動刷新
成交量:
1,180.62萬
成交額:
2.33億
市值:
62.40億
市盈率:
- -
高:
21.320
開:
16.400
低:
16.400
收:
16.330
52周最高:
45.040
52周最低:
10.800
股本:
3.32億
香港流通股本:
2.80億
量比:
1.33
換手率:
4.22%
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
-33.17%
市淨率:
5.62
市盈率(LYR):
- -
市銷率:
18120.21
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
麥科醫藥-B(02335)臨時股東大會延期至11月20日 過户登記停止期同步延長
公告速递
·
11/06
麥科醫藥-B盤中升逾30% 已取得MT200605 III期臨床試驗組長單位倫理批准
新浪港股
·
11/06
港股異動 | 麥科醫藥-B(02335.HK)再升逾28% 已取得MT200605 III期臨床試驗組長單位倫理批准
智通财经
·
11/06
異動解讀|麥科醫藥-B盤中上漲23.7%,國家重大專項經費到賬疊加Ⅲ期倫理獲批
行情直击
·
11/06
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/02335"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02335","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02335\",,,,,undefined,":{"symbol":"02335","market":"HK","secType":"STK","nameCN":"麥科醫藥-B","latestPrice":18.81,"timestamp":1793952530715,"preClose":16.33,"halted":0,"volume":11806200,"delay":0,"changeRate":0.15186772810777713,"floatShares":280071100,"shares":331740350,"eps":0,"marketStatus":"未開盤","change":2.48,"latestTime":"11-06 16:08:50","open":16.4,"high":21.32,"low":16.4,"amount":233359488,"amplitude":0.301286,"askPrice":18.81,"askSize":46800,"bidPrice":18.64,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-1.265,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":0,"adr":0,"listingDate":1782230400000,"exchange":"SEHK","adjPreClose":16.33,"openAndCloseTimeList":[[1793928600000,1793937600000],[1793941200000,1793952000000]],"volumeRatio":1.3261280771386093,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02335\",,,,,undefined,":{"symbol":"02335","floatShares":280071100,"roa":"-33.17%","roe":"--","lyrEps":0,"volumeRatio":1.3261280771386093,"shares":331740350,"dividePrice":0,"high":21.32,"amplitude":0.301286,"preClose":16.33,"low":16.4,"week52Low":10.8,"pbRate":"5.62","psRate":"18120.21","week52High":45.04,"institutionHeld":0,"latestPrice":18.81,"committee":-0.991489,"eps":0,"divideRate":0,"volume":11806200,"delay":0,"ttmEps":-1.265,"open":16.4,"prevYearClose":18.2,"prevWeekClose":11.6,"prevMonthClose":11.6,"prevQuarterClose":20.8,"fiveDayClose":11.6,"twentyDayClose":22.64,"sixtyDayClose":29.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02335\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02335","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02335\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02335\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02335\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02335","date":"2026-10-15","current":-14.869565,"percent":1,"low":-69.768231,"twenty":-56.795832,"median":-44.78361,"eighty":-17.096244,"high":-11.359199,"avg":-38.268805,"sd":18.620603,"marketCap":4853361320},"quantilePoints":[{"date":"2026-06-26","current":-62.263046,"twenty":-62.206329,"median":-60.152258,"eighty":-47.220229,"marketCap":13110378632},{"date":"2026-07-03","current":-59.036408,"twenty":-61.58898,"median":-58.586203,"eighty":-56.979685,"marketCap":12440263125},{"date":"2026-07-10","current":-67.90436,"twenty":-64.475349,"median":-60.719674,"eighty":-57.773147,"marketCap":14291374278},{"date":"2026-07-17","current":-63.579874,"twenty":-66.545041,"median":-62.752488,"eighty":-58.496163,"marketCap":13428849368},{"date":"2026-07-24","current":-53.390071,"twenty":-65.175311,"median":-60.719674,"eighty":-54.684103,"marketCap":11279171900},{"date":"2026-07-31","current":-45.013396,"twenty":-64.653423,"median":-59.036408,"eighty":-53.47914,"marketCap":9527582852},{"date":"2026-08-07","current":-44.926163,"twenty":-63.868877,"median":-57.071612,"eighty":-46.373695,"marketCap":9527582852},{"date":"2026-08-14","current":-46.337925,"twenty":-63.512285,"median":-53.986784,"eighty":-46.072055,"marketCap":9839418781},{"date":"2026-08-21","current":-45.768087,"twenty":-63.046152,"median":-53.612744,"eighty":-46.072055,"marketCap":9739896676},{"date":"2026-08-28","current":-44.884949,"twenty":-62.24414,"median":-48.311254,"eighty":-45.062515,"marketCap":9554122080},{"date":"2026-09-04","current":-22.281867,"twenty":-61.878748,"median":-47.732514,"eighty":-44.372782,"marketCap":9474504396},{"date":"2026-09-11","current":-17.12519,"twenty":-60.695027,"median":-47.077528,"eighty":-44.155643,"marketCap":7291652893},{"date":"2026-09-18","current":-17.133967,"twenty":-60.284432,"median":-46.489962,"eighty":-22.256011,"marketCap":7304922507},{"date":"2026-09-25","current":-16.480641,"twenty":-58.856326,"median":-46.039473,"eighty":-20.370807,"marketCap":7012990999},{"date":"2026-10-02","current":-16.961699,"twenty":-58.135999,"median":-45.362776,"eighty":-17.450855,"marketCap":7225304823},{"date":"2026-10-09","current":-17.173901,"twenty":-57.531245,"median":-44.96978,"eighty":-17.173901,"marketCap":7324826928},{"date":"2026-10-15","current":-11.359199,"twenty":-56.795832,"median":-44.78361,"eighty":-17.096244,"marketCap":4853361320}],"updateTime":1794166053845},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02335\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1185362540","title":"麥科醫藥-B(02335)臨時股東大會延期至11月20日 過户登記停止期同步延長","url":"https://stock-news.laohu8.com/highlight/detail?id=1185362540","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185362540?lang=zh_tw&edition=fundamental","pubTime":"2026-11-06 22:11","pubTimestamp":1793974282,"startTime":"0","endTime":"0","summary":"麦科医药-B公告称,为让股东有更充足时间审阅拟提呈决议案并作出安排,公司原定于11月10日举行的临时股东大会将顺延至2026年11月20日(周五)上午10时举行,地点不变。同时,原计划11月5日至11月10日暂停的股份过户登记,将延长至11月20日(含当日)。截至11月20日名列公司股东名册的H股及内资股股东,均可出席会议并参与投票。公司董事会确认,除会议日期及股份过户登记时间调整外,通函、通告及委任表格的其他资料均维持不变。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681833602","title":"麥科醫藥-B盤中升逾30% 已取得MT200605 III期臨床試驗組長單位倫理批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2681833602","media":"新浪港股","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681833602?lang=zh_tw&edition=fundamental","pubTime":"2026-11-06 11:21","pubTimestamp":1793935260,"startTime":"0","endTime":"0","summary":"按课题任务书及双方合作协议约定,本集团负责MT200605的研发、生产及临床试验供应。于MT200605II期临床试验完成后,本公司已收到本课题首笔中央财政专项经费,并正推动MT200605的临床开发迈向III期。本公司近期已取得MT200605用于治疗急性缺血性卒中患者的III期临床试验组长单位伦理委员会的批准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-11-06/doc-inixuiyw5035084.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","PSYK","IBBJ","IBBQ","MDTX","02335","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681384368","title":"港股異動 | 麥科醫藥-B(02335.HK)再升逾28% 已取得MT200605 III期臨床試驗組長單位倫理批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2681384368","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681384368?lang=zh_tw&edition=fundamental","pubTime":"2026-11-06 10:54","pubTimestamp":1793933690,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144627877","title":"異動解讀|麥科醫藥-B盤中上漲23.7%,國家重大專項經費到賬疊加Ⅲ期倫理獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=1144627877","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144627877?lang=zh_tw&edition=fundamental","pubTime":"2026-11-06 09:45","pubTimestamp":1793929559,"startTime":"0","endTime":"0","summary":"11月6日,麦科医药-B盘中上涨23.7%,报20.88港元,成交额7252.81万港元。消息面上,公司此前披露,MT200605相关课题已收到重大新药创制国家科技重大专项下首笔中央财政经费96万元,并取得急性缺血性卒中Ⅲ期临床试验组长单位伦理批准。上述进展意味着公司核心卒中管线在Ⅱ期达主要终点后,继续向Ⅲ期推进;同时后续经费拨付与课题节点挂钩,强化了市场对研发落地节奏的关注。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"麦科医药-B大涨,卒中Ⅲ期获批","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":27,"pageCount":1,"totalSize":107,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02335\",params:#limit:6,delay:false,,,undefined,":[]}}